# Colchicine Plus Phenolic Monoterpenes to Treat COVID-19

> **NCT04392141** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kermanshah University of Medical Sciences** · enrollment: 120 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Standard Treatment
- **DRUG:** Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions

## Key facts

- **NCT ID:** NCT04392141
- **Lead sponsor:** Kermanshah University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04392141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04392141, "Colchicine Plus Phenolic Monoterpenes to Treat COVID-19". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04392141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*